Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival

Fig. 2

Plasma symmetric dimethylarginine (SDMA) and asymmetric dimethylarginine (ADMA) in different sepsis severity groups. Patients were grouped according to their individual sequential organ failure assessment (SOFA) score and SDMA concentrations (a) and ADMA concentrations (b) are shown for day 1. Both SDMA and ADMA levels showed a trend towards increasing levels in patients with higher SOFA scores. Groups were compared using the Kruskal-Wallis test for trend analysis. Plots show median and interquartile range (IQR)

Back to article page

Critical Care

ISSN: 1364-8535